Research by two Texas A&M University scientists is focused on improving Lyme disease treatment outcomes by developing a test that's both more accurate and more efficient than the current test for the infection.
Jan 7, 2023
0
24
Rapid tests, which are easy to deploy and require minimal equipment, provide an important diagnostic tool in the ongoing effort against malaria, which affects more than 250 million people around the world annually. While ...
Jan 6, 2023
0
11
A study into the use of an at-home test that uses saliva rather than blood to diagnose adrenal insufficiency, which has been developed by scientists at the University of Sheffield and tested in Sheffield endocrine patients ...
Jan 6, 2023
0
34
Of the nearly 4 million births each year in the United States, roughly 50,000 are marked by life-threatening complications, and up to 900 result in maternal death during delivery. One major, often life-threatening complication ...
Jan 5, 2023
0
14
Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer screening are continually ...
Jan 4, 2023
0
4
Neurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3,000 individuals, and people with NF1 are at greater risk of developing a rare, aggressive form of cancer. Diagnosing malignant peripheral nerve ...
Jan 4, 2023
0
71
Too many Americans are missing out on a cure for hepatitis C, and a study underway in a hard-hit corner of Kentucky is exploring a simple way to start changing that.
Dec 20, 2022
0
3
The American College of Medical Genetics and Genomics (ACMG) has released a new Evidence-Based Clinical Practice Guideline (EBG), "Noninvasive prenatal screening for fetal chromosome abnormalities in a general-risk population: ...
Dec 16, 2022
0
3
If someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.
Dec 12, 2022
0
8
A discovery by Stanford School of Medicine researchers of biomarkers in the blood and urine of women with a dangerous complication of pregnancy could lead to a low-cost test to predict the condition.
Dec 12, 2022
0
46
